Clinical Education InitiativeMenu
Home > Courses > Update on Alternative Dosing Strategies for HIV Pre-Exposure Prophylaxis (PrEP)

Update on Alternative Dosing Strategies for HIV Pre-Exposure Prophylaxis (PrEP)

Update on Alternative Dosing Strategies for HIV Pre-Exposure Prophylaxis (PrEP)
Sorry, this learning module is not available for mobile devices.
Original Presentation: 9/8/2015
Web Posting: 1/18/2016
CE Expiration: 09/08/2018
  • Sharon Mannheimer, MD
    Assistant Professor of Clinical Medicine
    Columbia College of Physicians & Surgeons
Learning Objectives
At the completion of this educational session, participants will:
  1. Become familiar with the findings of the IPERGAY and ADAPT studies of intermittent PrEP.
  2. Learn the main side effects of PrEP.
  3. Understand common barriers to PrEP adherence.
Presenter Bio
Sharon Mannheimer, MD
Dr. Mannheimer’s career in Infectious Diseases has focused on HIV, including clinical care of HIV-infected patients, research on adherence to HIV therapy, and also research on HIV prevention. Dr. Mannheimer helps oversee HIV Services at Harlem Hospital including several Ryan White-funded programs, which provide primary care and other supportive HIV services for residents of Harlem and neighboring communities. She is currently involved in conducting HIV prevention research as the Site Leader of the NIH-funded Harlem Prevention Center Clinical Research Site, located in Harlem and part of ICAP in Columbia’s Mailman School of Public Health. She was the Site Principal Investigator of the ADAPT Study, an HIV Prevention Trials Network study assessing dosing strategies for pre-exposure prophylaxis (PrEP) medication to prevent HIV infection among at risk HIV negative individuals in New York City. She also previously served as member of the Priority Setting and Resource Allocation Committee of the HIV Health and Human Services Planning Council of New York City, and was a past elected member of the New York State Medical Care Criteria Committee, which develops New York State HIV clinical practice guidelines HIV-infected adults.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on September 8, 2015 and will terminate September 7, 2018.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length. 

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity. 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose. 
  • Dr. Sharon Mannheimer (Presenter) had no relevant financial relationships to disclose. Dr. Mannheimer submitted her slides in advance for adequate peer review, and will support her presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

PRN Learning Modules